Additional diagnostic markers of comorbid version of vibration disease combined with arterial hypertension

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Vibration disease (VD) in combination with arterial hypertension (AH) today is one of the leading problems in therapeutic clinical practice and occupational medicine.

The aim: to study additional clinical-functional, nutritional-metabolic and molecular-genetic diagnostic markers of the comorbid variant of VD in combination with arterial hypertension.

Material and methods. A single-center, open, non-randomized, cross-sectional study was performed. All the participants were divided into four groups: 1st – patients with isolated VD (n = 104); 2nd – patients with arterial hypertension (n = 107); 3rg group – patients with comorbid model of VD + arterial hypertension (n = 101); 4th (control group) – conditionally healthy individuals working at the same enterprise without contact with vibration and not suffering from hypertension (n = 119).

Results. The following most significant changes were revealed in VB + AH group: an increase in the frequency of general and specific complaints, high body mass index values corresponding to obesity of the 2nd and 3rd degrees, decrease in active cell mass and phase angle, decrease of adipocytokine profile indexes, lower vitamin D levels comparatively to other groups (all p < 0.0001). It was found that the molecular picture of inflammation in case of VD combined with arterial hypertension differs significantly from that in case of isolated VD and case of isolated hypertension. When studying a group of patients with VD + arterial hypertension, it was found that the increased frequency of T/T rs4880 genotype of superoxide dismutase SOD2 gene appears to be a characteristic of oxidative stress.

Conclusion. Formation of VD, combined with arterial hypertension, occurs secondary to nutritional and metabolic disorders in association with clinical and functional parameters, changes in adipocytokine status, systemic inflammation, vitamin D levels, endothelial dysfunction and oxidative stress, as well as an increased frequency of detection of the polymorphic variant of T/T locus Ala 16 Val (rs4880) of the MnSOD (superoxide dismutase) gene.

全文:

受限制的访问

作者简介

Alena Gorbunova

Novosibirsk State Medical University of the Ministry of Healthcare of Russia

编辑信件的主要联系方式.
Email: belyaeva-alena@list.ru
ORCID iD: 0000-0002-1593-3984

MD, postgraduate student, assistant, head of the educational unit of the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine

俄罗斯联邦, 630005, Novosibirsk, 71 Demyana Bednogo St.

Oksana Gerasimenko

Novosibirsk State Medical University of the Ministry of Healthcare of Russia

Email: profgerasimenko@inbox.ru
ORCID iD: 0000-0002-9742-0479

MD, Dr. Sci. (Medicine), professor, head of the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine

俄罗斯联邦, 630005, Novosibirsk, 71 Demyana Bednogo St.

Ilya Shpagin

Novosibirsk State Medical University of the Ministry of Healthcare of Russia

Email: Dr.ilya.shpagin@gmail.ru

MD, Dr. Sci. (Medicine), associate professor of the Department of hospital therapy and medical rehabilitation of the Faculty of pediatrics

俄罗斯联邦, 630051, Novosibirsk, 21 Polzunova St.

Tatyana Belyaeva

Semey Medical University of the Ministry of Healthcare of the Republic of Kazakhstan

Email: btm56@rambler.ru
ORCID iD: 0000-0002-2565-2393

MD, PhD (Medicine), associate professor of the Department of general medical practice

哈萨克斯坦, 071400, Semey, 103 Abaya St.

Anastasia Tolmacheva

Semey Medical University of the Ministry of Healthcare of the Republic of Kazakhstan

Email: tolmacheva_nastena@mail.ru
ORCID iD: 0000-0003-1687-4100

MD, PhD (Medicine), assistant at the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine

哈萨克斯坦, 071400, Semey, 103 Abaya St.

Vladimir Maksimov

Novosibirsk State Medical University of the Ministry of Healthcare of Russia; Research Institute of Therapy and Preventive Medicine – a branch of the Federal Research Center “Institute of Cytology and Genetics of the Siberian branch of the Russian Academy of Sciences”

Email: medik11@mail.ru
ORCID iD: 0000-0002-7165-4496

MD, Dr. Sci. (Medicine), professor, professor of the Department of medical genetics and medical biology

俄罗斯联邦, 630005, Novosibirsk, 71 Demyana Bednogo St.; 630089, Novosibirsk, 175/1 B. Bogatkova St.

参考

  1. Кулешова М.В., Панков В.А., Дьякович М.П. с соавт. Вибрационная болезнь у работников авиастроительного предприятия: факторы формирования, клинические проявления, социально-психологические особенности. Гигиена и санитария. 2018; 97(10): 915–920. [Kuleshova M.V., Pankov V.A., Dyakovich M.P. et al. The vibration disease in workers of the aircraft enterprise: Factors of the formation, clinical manifestations, social-psychological features (dynamic following-up). Gigiena i sanitariya = Hygiene and Sanitation. 2018; 97(10): 915–920 (In Russ.)]. https://doi.org/10.47470/0016-9900-2018-97-10-915-920. EDN: SKOZPR.
  2. Хоменко А.О., Якшина Н.В., Мушников В.С. с соавт. Влияние виброакустических факторов на безопасность и здоровье работников промышленных предприятий. Экономика труда. 2022; 9(12): 2175–2196. [Khomenko A.O., Yakshina N.V., Mushnikov V.S. et al. The influence of vibroacoustic factors on the safety and health of industrial employees. Ekonomika truda = Russian Journal of Labor Economics. 2022; 9(12): 2175–2196 (In Russ.)]. https://doi.org/10.18334/et.9.12.116410. EDN: PPCIHN.
  3. Чистова Н.П., Маснавиева Л.Б., Кудаева И.В. Вибрационная болезнь: дозостажевые характеристики и особенности клинической картины при воздействии локальной вибрации и сочетанном воздействии локальной и общей вибрации. Здоровье населения и среда обитания. 2021; 29(12): 30–35. [Chistova N.P., Masnavieva L.B., Kudaeva I.V. Vibration disease: Exposure level and duration-dependent characteristics and features of the clinical picture following local and combined local and whole body vibration. Zdorov’e naseleniya i sreda obitaniya = Public Health and Life Environment. 2021; 29(12): 30–35 (In Russ.)]. https://doi.org/10.35627/2219-5238/2021-29-12-30-35. EDN: IBZXSN.
  4. Оганов Р.Г., Симаненков В.И., Бакулин И.Г. с соавт. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1): 5–66. [Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Kardiovaskuljarnaja terapija i profilaktika = Cardiovascular Therapy and Prevention. 2019; 18(1): 5–66 (In Russ.)]. https://doi.org/10.15829/1728-8800-2019-1-5-66. EDN: YXKKAP.
  5. Ямщикова А.В., Флейшман А.Н., Гидаятова М.О. Коморбидные состояния у больных вибрационной болезнью. Гигиена и санитария. 2019; 98(7): 718–722. [Yamshchikova A.V., Fleishman A.N., Gidayatova M.O. Co-morbid conditions in the vibration disease patients. Gigiena i sanitariya = Hygiene and Sanitation. 2019; 98(7): 718–722 (In Russ.)]. https://doi.org/10.18821/0016-99002019-98-7-718-722. EDN: AFHZBA.
  6. Рахманова О.В. Выраженность оксидативного, нитрозативного и карбонильного стрессов у пациентов разного возраста, страдающих артериальной гипертонией. Здоровье и образование в XXI веке. 2018; 20(5): 25–29. [Rakhmanova O.V. The severity of oxidative, nitrosative and carbonyl stresses in patients of different ages with arterial hypertension. Zdorov’e i obrazovanie v XXI veke = Health and Education in the 21st Century. 2018; 20(5): 25–29 (In Russ.)]. https://doi.org/10.26787/nydha-2226-7425-2018-20-5-25-29. EDN: UPPKGP.
  7. Герасименко О.Н., Шпагина Л.А., Горбунова А.М. с соавт. Клинико-функциональная и молекулярная характеристика коморбидной патологии (вибрационная болезнь в сочетании с артериальной гипертензией). Атеросклероз. 2022; 18(1): 68–75. [Gerasimenko O.N., Shpagina L.A., Gorbunova A.M. et al. Clinical-functional and molecular characteristics of comorbid pathology (vibration disease combined with arterial hypertension). Ateroskleroz = Atherosclerosis. 2022; 18(1): 68–75 (In Russ.)]. https://doi.org/10.52727/2078-256X-2022-18-1-68-7. EDN: YDJOVZ.
  8. Бабанов С.А., Бараева Р.А., Стрижаков Л.А. с соавт. Цитокиновая регуляция и эндотелиальная дисфункция при сочетании вибрационной болезни и артериальной гипертензии. Терапевтический архив. 2021; 93(6): 693–698. [Babanov S.A., Baraeva R.A., Strizhakov L.A. et al. The state of cytokine regulation and endothelial dysfunction in the combined course of vibration disease and arterial hypertension. Terapevticheskiy arkhiv = Therapeutic Archive. 2021; 93(6): 693–698 (In Russ.)]. https://doi.org/10.26442/00403660.2021.06.200880. EDN: KZWGFK.
  9. Смирнова Е.Л., Потеряева Е.Л., Никифорова Н.Г. Индивидуальные особенности перекисного окисления липидов и антиоксидантной защиты у лиц с вибрационной болезнью в послеконтакном периоде. Медицина труда и промышленная экология. 2010; (8): 36–40. [Smirnova E.L., Poteryayeva E.L., Nikiforova N.G. Individual features of lipid peroxidation and antioxidant defence in vibration disease patients at post-contact period. Meditsina truda i promyshlennaya ekologiya = Russian Journal of Occupational Health and Industrial Ecology. 2010; (8): 36–40 (In Russ.)]. EDN: MUHGXV.
  10. Малютина Н.Н., Болотова А.Ф., Еремеев Р.Б. с соавт. Антиоксидантный статус крови у пациентов с вибрационной болезнью. Медицина труда и промышленная экология. 2019; 59(12): 978–982. [Malyutina N.N., Bolotova A.F., Eremeev R.B. et al. Antioxidant status of blood in patients with vibration disease. Meditsina truda i promyshlennaya ekologiya = Russian Journal of Occupational Health and Industrial Ecology. 2019; 59(12): 978–982 (In Russ.)]. https://doi.org/10.31089/1026-9428-2019-59-12-978-982. EDN: ZPVTXP.
  11. Гуманова Н.Г. Оксид азота, его циркулирующие метаболиты NOx и их роль в функционировании человеческого организма и прогнозе риска сердечно-сосудистой смерти (часть I). Профилактическая медицина. 2021; 24(9): 102–109. [Gumanova N.G. Nitric oxide and its circulating NOX metabolites, their role in human body functioning and cardiovascular death risk prediction (part I). Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2021; 24(9): 102–109 (In Russ.)]. https://doi.org/10.31089/1026-9428-2019-59-12-978-982. EDN: VOEXBV.
  12. Третьяков С.В. Состояние сердечно-сосудистой системы при действии вибрации (клинические и патогенетические аспекты). Международный научно-исследовательский журнал. 2023; (9): 1–20. [Tretyakov S.V. Condition of cardiovascular system under vibration (clinical and pathogenetic aspects). Mezhdunarodnyy nauchno-issledovatel’skiy zhurnal = International Research Journal. 2023; (9): 1–20 (In Russ.)]. https://doi.org/10.23670/IRJ.2023.135.38. EDN: ENTIMT.
  13. Береза И.А., Амромина А.М., Шаихова Д.Р. с соавт. Полиморфизм Ala16Val гена супероксиддисмутазы 2 (SOD2) и факторы сердечно-сосудистого риска работников металлургического комбината. Гигиена и санитария. 2023; 102(5): 457–461. [Bereza I.A., Amromina A.M., Shaikhova D.R. et al. Relationship of the superoxide dismutase 2 (SOD2) gene Ala16Val polymorphism with risk factors for the cardiovascular disease in iron and steel production employees. Gigiena i sanitariya = Hygiene and Sanitation. 2023; 102(5): 457–461 (In Russ.)]. https://doi.org/10.47470/0016-9900-2023-102-5-457-461. EDN: PPESVO.
  14. Чистова Н.П. Роль полиморфизмов генов-кандидатов эндотелиальной дисфункции и метаболических нарушений в развитии сердечно-сосудистых заболеваний при воздействии производственных факторов. Медицина труда и промышленная экология. 2022; 62(5): 331–336. [Chistova N.P. The role of candidate gene polymorphisms for endothelial dysfunction and metabolic disorders in the development of cardiovascular diseases under the influence of production factors. Meditsina truda i promyshlennaya ekologiya = Russian Journal of Occupational Health and Industrial Ecology. 2022; 62(5): 331–336 (In Russ.)]. https://doi.org/10.31089/1026-9428-2022-62-5-331-336. EDN: JDNIWU.
  15. Decharatchakul N., Settasatian C., Settasatian N. et al. Association of genetic polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with hypertriglyceridemia and low HDL-C level in subjects with high risk of coronary artery disease. PeerJ. 2019; 7: e7407. https://doi.org/10.7717/peerj.7407. PMID: 31396447. PMCID: PMC667991.
  16. Клинические рекомендации. Артериальная гипертензия у взрослых. Общероссийская общественная организация «Российское кардиологическое общество». Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 62. Доступ: https://cr.minzdrav.gov.ru/recomend/62_2 (дата обращения – 14.06.2024). [Clinical guidelines. Arterial hypertension in adults. Russian Society of Cardiology. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 62. URL: https://cr.minzdrav.gov.ru/recomend/62_2 (date of access – 14.06.2024) (In Russ.)].

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2024
##common.cookie##